Select Medical Holdings Corp

Select Medical Holdings Corp(SEM)の株式分析

$16.510

-0.020 (-0.12%)終値時点

Loading chart…
高値
16.560
始値
16.530
出来高加重平均価格
16.53
出来高
27.84M
時価総額
4.56B
安値
16.510
売買代金
460.09M
EV/EBITDA(TTM)
9.06

Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia.

www.selectmedical.com

AI分析 of Select Medical Holdings Corp (SEM)

中立

Select Medical Holdings Corp (SEM) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is being acquired for $16.50 per share in cash, effectively capping its upside potential. Additionally, there are no significant trading signals or positive catalysts to suggest a compelling entry point.

アナリスト評価(6)

上値余地 +13.57%
買い
4 買い
0 中立
2 売り
現在: 16.51
安値
17.00
平均
18.75
高値
21.00

Mizuho

2026-05-12

目標株価

$17

中立

RBC Capital

2026-02-23

目標株価

$19

アウトパフォーム

BofA

2025-11-25

目標株価

—

No Rating

BofA

2025-09-10

目標株価

$15

買い

UBS

2025-08-04

目標株価

$14

中立

バリュエーション指標

Select Medical Holdings Corp(SEM)の現在の予想PERは13.42で、5年平均は13.78です。

予想PER

適正
5年平均 P/E
13.78
現在のP/E
13.42
割高
16.29
割安
11.27

予想EV/EBITDA

割安
5年平均 EV/EBITDA
10.31
現在のEV/EBITDA
9.06
割高
11.33
割安
9.30

予想PSR

割安
5年平均 P/S
0.47
現在のP/S
0.34
割高
0.59
割安
0.36

Alphio AI による SEM の価格シナリオ

シナリオ価格は本年の最終月次予想レンジです。確率はモデルの固定ウェイト(25 / 50 / 25)であり、保証ではありません。

強

強気

強気 · 25%SEM

$15.70

シナリオ価格

基

基本

基本 · 50%SEM

$13.55

シナリオ価格

弱

弱気

弱気 · 25%SEM

$11.91

シナリオ価格

SEM を保有するクジラ

E

Eversept Partners, L.P.

+ を保有SEM

-7.76%

3か月リターン

イベントタイムライン

2026-06-30 (ET)

16:30:00

Select Medical Completes Acquisition, Ceases Trading

2026-06-26 (ET)

17:30:00

Select Medical Holdings to be Acquired

2026-05-21 (ET)

09:10:00

Select Medical and Carilion Clinic Partner to Build 50-Bed Rehab Hospital

2026-04-30 (ET)

16:50:00

Sees FY25 Adjusted EBITDA at $520M-$540M

16:40:00

Company Reports Q1 Revenue of $1.421B

ニュース

SEM のよくある質問 — Alphio AI が回答

Select Medical Holdings Corporation operates critical illness recovery hospitals, rehabilitation hospitals, and outpatient rehabilitation clinics in the United States. Its segments include Critical Illness Recovery Hospital, Rehabilitation Hospital, and Outpatient Rehabilitation. Critical Illness Recovery Hospital segment consists of hospitals designed to serve the needs of patients recovering from critical illnesses, often with complex medical needs. It operates the majority of its critical illness recovery hospitals as a hospital within a hospital (an HIH). Rehabilitation Hospital segment serves patients that require intensive physical rehabilitation care. Outpatient Rehabilitation segment consists of clinics that provide physical, occupational, and speech rehabilitation services. It operates around 105 critical illness recovery hospitals in 29 states, 36 rehabilitation hospitals in 14 states, and 1,922 outpatient rehabilitation clinics in 39 states and the District of Columbia. It operates in the Healthcare sector (SERVICES-HOSPITALS industry).

Select Medical Holdings Corp (SEM) is not a good buy for a beginner investor with a long-term strategy and $50,000-$100,000 available for investment. The stock is being acquired for $16.50 per share in cash, effectively capping its upside potential. Additionally, there are no significant trading signals or positive catalysts to suggest a compelling entry point.

6 analysts cover SEM: 4 rate it Buy, 0 Hold and 2 Sell. The average price target is 18.75.

コミュニティ

もっと見る ↗

投稿はまだありません

登録またはログインして議論に参加

本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。

取引を始める